Announcements Trials

Browse Landscape

Phase

Status

Recruiting 10 Enrolling by invitation 3 Completed 2 Withdrawn 1 Terminated 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 28 Neoplasms 26 Prostatic Neoplasms 22 Colorectal Neoplasms 18 Head and Neck Neoplasms 14 Pancreatic Neoplasms 12 Melanoma 10 Lung Neoplasms 10 Brain Neoplasms 10 Neoplasm Metastasis 9 Carcinoma, Renal Cell 9 Squamous Cell Carcinoma of Head and Neck 8 Carcinoma, Non-Small-Cell Lung 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Lymphoma, Follicular 7 Lymphoma 7 Glioblastoma 7 Ovarian Neoplasms 6 Leukemia, Myeloid, Acute 6 Leukemia 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Lymphoma, B-Cell 5 Kidney Neoplasms 5 Hematologic Neoplasms 5 Sarcoma 4 Liver Neoplasms 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Adenoviridae Infections × 1 year × Clear all

NCT02143804 2026-04-02

exBOND

CG Oncology, Inc.

Phase 2 Withdrawn

Adenoviridae Infections, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡